GitLab Stock Is Down 70% From 2021 Highs but One Fund Is Betting $10 Million on Its Performance

Massachusetts-based TFJ Management disclosed a third-quarter purchase of 116,490 GitLab (GTLB) shares, raising its position to 221,259 shares with a quarter-end market value of $9.97 million and representing 6.72% of its reported 13F AUM; the incremental buy increased the stake by an estimated $5.25 million. GitLab trades at $38.00 (down ~32% over the past year) with a $6.4 billion market cap; recent operating results show revenue of $244.4 million in the latest quarter (up 25% year-over-year), TTM revenue of $906.25 million, adjusted free cash flow of $27.2 million, a non-GAAP operating margin of 18%, dollar-based net retention of 119%, and 23% growth in >$100k customers. The filing signals institutional conviction in a volatile enterprise-software name where fundamentals are improving despite a large drawdown from post-IPO highs, implying opportunity for patient, growth-oriented investors without concentrated exposure.

Analysis

Market structure: TFJ’s third‑quarter accumulation of 116k GTLB shares signals selective institutional appetite for volatile, high‑growth DevOps exposure; direct beneficiaries are GitLab (GTLB) and its enterprise customers, while legacy point solutions (internal CI/CD tooling, smaller niche vendors) face pressure. With TTM revenue ~$906m and market cap $6.4bn, the stock trades as a growth multiple (~7x revenue) despite ~25% top‑line growth—pricing reflects demand for re‑risked growth rather than immediate cash flow conversion.

Risk assessment: Tail risks include a sharp enterprise IT spend pullback ( >10% y/y contraction in cyclical budgets), a security breach undermining trust, or aggressive open‑source competition that could drop dollar retention below 110%; any of these could erase >40% of market cap. Immediate impact (days) will be headline‑sensitive, short term (0–6 months) hinges on guidance/DBNR cadence, long term (12–36 months) depends on sustaining >20% ARR growth and margin expansion to 15–20% adjusted operating margin.

Trade implications: Direct play—establish a tactical 2–3% portfolio long in GTLB on entries <=$38, add on pullback to <$25; target 12–24 month upside 50–100% if growth/margins continue. Option strategies—buy Jan 2027 LEAP calls (1x $40 strike) for asymmetric upside or a 6‑month call spread (buy Mar 2026 $35, sell Mar 2026 $55) to cap cost; sell 90‑day cash‑secured $30 puts to acquire on weakness.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in GitLab (GTLB) at market price <= $38; set an initial 20% trailing stop and plan to hold 12–24 months with upside target 50–100% if revenue growth remains >=20% and adjusted operating margin approaches 15–20%.
• Execute a relative‑value pair: long GTLB (notional X) and short Atlassian (TEAM) at 0.6x notional (short smaller) for 12 months to express share‑gain thesis in DevOps; rebalance if GTLB/TEAM price ratio moves >20% from entry.
• Use options for asymmetric exposure: buy Jan 2027 LEAP calls (approx. $40 strike) sized to equal 1–1.5% portfolio risk, or deploy a lower‑cost Mar 2026 call spread (buy $35 / sell $55) to limit premium; alternatively sell a 90‑day cash‑secured put at $30 to collect premium and set max assignment price.
• Reduce cyclical defensive overweights by 1–2% to fund GTLB exposure; reallocate into enterprise SaaS names with DBNR >110% and positive FCF (e.g., GTLB, DDOG) and trim outperformance tech if macro PMI slips below 50 for two consecutive months.